DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Basmisanil is an investigational drug.
There have been 3 clinical trials for Basmisanil. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2016.
The most common disease conditions in clinical trials are Schizophrenia, Cognition Disorders, and Stroke. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
Recent Clinical Trials for Basmisanil
|A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke||Hoffmann-La Roche||Phase 2|
|A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics||Hoffmann-La Roche||Phase 2|
|A Brain Imaging Study to Assess GABAA Receptor Alpha5 Subunit Occupancy Following a Single Dose of RO5186582 in Japanese Healthy Volunteers.||Hoffmann-La Roche||Phase 1|